Mike Hamill

Dad & Biochemist, working on Venture Creation @flagshippioneer

[Flagship Pioneering @FlagshipPioneer]

WATCH AND LISTEN: At Flagship Pioneering, 2021 was a year for bold leaps, advancing breakthroughs to improve human health and the sustainability of our planet.

[Flagship Pioneering @FlagshipPioneer]

Flagship is an experiment in institutional innovation – creating breakthroughs & transformational companies. We're seeking scientists, engineers, physicians & AI/ML researchers for our 2022 Summer Flagship Fellowship. Apply now: https://t.co/LaWCa17YQb
https://t.co/XZtQhn3UH9

[Mike Hamill @biotech_mike]

This Little Company Thinks It Can Beat Long Covid https://t.co/2VIzjOXiGK via @BarronsOnline

[Boston Business Journal @BosBizJournal]

In a near-first for the biotech industry, Axcella Therapeutics Inc. is launching a clinical study investigating a new drug to treat "long Covid." https://t.co/0XrOOEvTaG

[Nature Reviews Molecular Cell Biology @NatRevMCB]

Now Online Molecular mechanisms of dietary restriction promoting health and longevity https://t.co/4mSKQO4612

[Flagship Pioneering @FlagshipPioneer]

Flagship-founded Axcella is pioneering multi-targeted therapies for complex diseases using its novel #EMM #bioplatform. What are #EMMs and how do they work? Check out this video to learn more: https://t.co/IHrwMjj8X5 https://t.co/r7ZaTXTyYE

[Demetriades Lab @DemetriadesLab]

📢 Happy to share our review paper on the regulation of mTORC1 by nutrients and the role of nutrient sensing pathways in ageing and physiology, online today in @FrontAging.
Amazing effort by @stephalcantara! 🏅
Thanks to @LammingLab for the invitation.
👇
https://t.co/n4IKJxcy5Z

[Flagship Pioneering @FlagshipPioneer]

#EmergentDiscovery is a Darwinian process of intellectual leaps leading to #breakthroughs. In this @HarvardBiz article by Flagship CEO @NoubarAfeyan & @HarvardHBS Professor Gary Pisano, they share how to put these principles into action. @motogp61 https://t.co/GRwQdVaKKT

[Mike Hamill @biotech_mike]

Results from AXA1125-003 clinical study in subjects with presumed #NASH just published in the American Journal of Gastroenterology. https://t.co/pxsXWrw6Gc

[Jason Locasale @LocasaleLab]

Our study now @biorxivpreprint - algorithms to analyze amino acid composition and intake in human food, dietary patterns (keto, Mediterranean, western etc), and health. Perhaps counter intuitive findings on the nature of protein intake in diet. https://t.co/GoQrfXe0Ut

[Timothy Caulfield @CaulfieldTim]

For the (few) track nerds on my feed!

"This means that primarily MAS [maximal aerobic speed] & sprint ability determined 800m performance."

https://t.co/Am6JlhOc4Q [small N] cc @TStellingwerff @mackinprof

800 such a cool/tough event. Perfect mix of speed (!) & endurance.

[Scientific Reports @SciReports]

This study has looked into the bouncing behavior of sub-four minute milers #Biomechanics https://t.co/cL3CmPd6iq

[Mike Hamill @biotech_mike]

Just published our foundational non-clinical work on AXA1125 in @SciReports ! So much went into this from an amazing research team #physiologicalmedia #aminoacids #NASH #metabolism #emms #axcellahealth
https://t.co/nRvUgtiNKk

[Mike Hamill @biotech_mike]

@mackinprof @DrMJoyner @hjluks @onepeloton Way to bring it @mackinprof this should be a thing! @MattWilpers #teamwilpers

[Mike Hamill @biotech_mike]

Really excited to share our first Perspective article on EMMs in @iScience_CP. Here we highlight the wealth of data on EMMs and how that enables the rational design of EMM compositions. #axcella #metabolism #emms #aminoacids #iscience

https://t.co/M4n23vkZFl

[Nature Metabolism @NatMetabolism]

Online now! Mind your media https://t.co/wLqZd7vo1C

[Mike Hamill @biotech_mike]

New publication out today on safety, tolerability, and physiological effects of AXA1665 in subjects with cirrhosis

https://t.co/vjEMH70QQQ

[Cell Metabolism @Cell_Metabolism]

Quantitative Fluxomics of Circulating Metabolites https://t.co/Xr7elukru4

[Noubar Afeyan @NoubarAfeyan]

Good day for the microbiome field, the pioneering company Seres in particular, and for those few who dare work on inventing new classes of medicines despite the odds. Congrats to the whole team @SeresTX and to colleagues @FlagshipPioneer who created its origins. $evlo $kldo $mcrb

[Mike Hamill @biotech_mike]

Excited to report our top-line data from AXA1665-002 showing dose dependent improvements in markers of cognitive function and amino acid metabolism https://t.co/MAY1fOfyBB